STERLING DEESIDE LIMITED

Active Deeside

Research and experimental development on biotechnology

62 employees website.com
Research and experimental development on biotechnology
S

STERLING DEESIDE LIMITED

Research and experimental development on biotechnology

Founded 26 Apr 2010 Active Deeside, Wales 62 employees website.com
Research and experimental development on biotechnology

Previous Company Names

ADC BIOTECHNOLOGY LIMITED 18 May 2010 — 3 Apr 2021
REAXA BIOTECH LTD 26 Apr 2010 — 18 May 2010
Accounts Submitted 18 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 11 Jun 2025 Next due 14 Jun 2026 1 month remaining
Net assets £-4M £2M 2024 year on year
Total assets £10M £647K 2024 year on year
Total Liabilities £13M £3M 2024 year on year
Charges 5
1 outstanding 4 satisfied

Contact & Details

Contact

Registered Address

Unit 103 Tenth Avenue Deeside Industrial Park Deeside CH5 2UA Wales

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for STERLING DEESIDE LIMITED (07235280), an active company based in Deeside, Wales. Incorporated 26 Apr 2010. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£528.20k

Increased by £241.03k (+84%)

Net Assets

-£3.53M

Decreased by £2.16M (-159%)

Total Liabilities

£13.24M

Increased by £2.81M (+27%)

Turnover

£7.80M

Employees

62

Increased by 6 (+11%)

Debt Ratio

136%

Increased by 21 (+18%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

22 Allotments 367,023,519 Shares £12.39m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Nov 2020216,446,306£2.00m£0.009
14 Aug 2020266,382£2.664£0
27 Jul 2020999,999£10£0
27 Mar 202020,341,504£824k£0.041
17 Jan 202027,757,802£1.12m£0.041

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Sterling Pharma Solutions Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 30 Nov 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Dbw Holdings Limited

Ceased 30 Nov 2020

Ceased

Group Structure

Group Structure

STERLING DEESIDE LIMITED Current Company

Charges

Charges

1 outstanding 4 satisfied

Properties

Properties

2 leasehold 2 total
AddressTenurePrice PaidDate Added
Land on the north-east side of Unit 103, Tenth Avenue, Deeside Industrial Park, Deeside (CH5 2UA) FLINTSHIRE
Leasehold-9 Oct 2017
Unit 103, Tenth Avenue, Deeside Industrial Park, Deeside (CH5 2UA) FLINTSHIRE
Leasehold-9 Oct 2017
Land on the north-east side of Unit 103, Tenth Avenue, Deeside Industrial Park, Deeside (CH5 2UA)
Leasehold
Added 9 Oct 2017
District FLINTSHIRE
Unit 103, Tenth Avenue, Deeside Industrial Park, Deeside (CH5 2UA)
Leasehold
Added 9 Oct 2017
District FLINTSHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
20 Apr 2026CapitalAllotment of shares (GBP 5,593.27632) on 31 Mar 2026
18 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
18 Dec 2025AccountsAnnual accounts filed
14 Nov 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/03/25
14 Nov 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/03/25
20 Apr 2026 Capital

Allotment of shares (GBP 5,593.27632) on 31 Mar 2026

18 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

18 Dec 2025 Accounts

Annual accounts filed

14 Nov 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

14 Nov 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/03/25

Recent Activity

Latest Activity

Allotment of shares (GBP 5,593.27632) on 31 Mar 2026

3 weeks ago on 20 Apr 2026

Annual accounts made up to 31 Mar 2025

4 months ago on 18 Dec 2025

Annual accounts filed

4 months ago on 18 Dec 2025

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

5 months ago on 14 Nov 2025

Audit exemption statement of guarantee by parent company for period ending 31/03/25

5 months ago on 14 Nov 2025